PulseAugur
中
实时 23:16:03

New TMLE methods boost subgroup analysis in clinical trials

作者 PulseAugur 编辑部 · [2 个来源] ·

Researchers have developed new statistical methods, specifically two Targeted Maximum Likelihood Estimators (TMLEs), to improve the power of subgroup analyses in randomized controlled trials. These methods, TMLE-PR and A-TMLE, allow for information sharing among participants within the same trial, including those not in the specific subgroup of interest, without using external data. This approach aims to enhance the precision of treatment effect estimates for smaller subgroups, aligning with regulatory goals to support equitable access and evaluation. AI

影响 Enhances statistical rigor in clinical trials, potentially improving the precision of treatment effect estimates for underrepresented patient groups.

排序理由 The cluster contains an academic paper detailing new statistical methodology. [lever_c_demoted from research: ic=2 ai=0.4]

在 arXiv stat.ML 阅读 →

AI 生成摘要 · Google Gemini · 来自 2 个来源。 我们如何撰写摘要 →

New TMLE methods boost subgroup analysis in clinical trials

报道来源 [2]

  1. arXiv stat.ML TIER_1 English(EN) · Sky Qiu, Nerissa Nance, Rachael Phillips, Jens Tarp, Maya Petersen, Mark van der Laan ·

    Improving the Efficiency of Subgroup Analysis in Randomized Controlled Trials with TMLE

    arXiv:2605.15483v1 Announce Type: cross Abstract: Subgroup analyses within randomized controlled trials are often underpowered due to limited sample sizes. We address this challenge by leveraging trial participants outside the subgroup of interest to augment estimation within the…

  2. arXiv stat.ML TIER_1 English(EN) · Mark van der Laan ·

    Improving the Efficiency of Subgroup Analysis in Randomized Controlled Trials with TMLE

    Subgroup analyses within randomized controlled trials are often underpowered due to limited sample sizes. We address this challenge by leveraging trial participants outside the subgroup of interest to augment estimation within the subgroup. Specifically, we study two Targeted Max…

相关实体

相关话题